Live Chat

تداول AstraZeneca AZN

AstraZeneca live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date إغلاق change معدل التغيير (%) instr__open مرتفع منخفض

Markets.com news

bitcoin dropping
Antonio Ferlito 2024 Aug 19, 16:05

Test News Article Arabic Only

CFD Trading BoE
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

الأسبوع القادم: نتائج الانتخابات الفرنسية هامة بالنسبة للأسواق الأوروبية

الفوركس المؤشرات
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

الأسبوع القادم: هل تتسبب فرنسا في أزمة جديدة لليورو؟

CPI
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

الأسبوع القادم: البنك الأسترالي، البنك البريطاني.. الثبات أم التغيير؟

الفوركس المؤشرات

معلومات

الفارق الهامشي

66.25

الهامش (%)

0.6407 %

الرافعة المالية

1:10

فائدة الشراء بين ليلة وضحاها

-0.0590 %

فائدة البيع بين ليلة وضحاها

-0.0299 %

عملة

PNC

ساعات التداول

السوق مغلق

الثلاثاء

08:01 - 11:59

الاثنين

08:01-11:59

الاثنين

12:03-16:29

الأربعاء

08:01-11:59

الأربعاء

12:03-16:29

الخميس

08:01-11:59

الخميس

12:03-16:29

الجمعة

08:01-11:59

الجمعة

12:03-16:29

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

161574354944

instr__shares_outstand

1550320000

instr__earnings_date

0000-00-00

instr__dividend_date

instr__ex_dividend_date

2024-08-08

instr__forward_annual_dividend_rate

2.34

instr__forward_annual_dividend_yield

0.0228

instr__eps

3.26

instrument_learn_more

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

related_instruments

الأصل
البيع
شراء
معدل التغيير (%)
view_all_instruments
Trustpilot
Live Chat